Wine and Your Heart
Open Access
- 23 January 2001
- journal article
- guideline
- Published by Wolters Kluwer Health in Circulation
- Vol. 103 (3) , 472-475
- https://doi.org/10.1161/01.cir.103.3.472
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein CholesterolNew England Journal of Medicine, 1999
- Alcohol Consumption and Mortality among Middle-Aged and Elderly U.S. AdultsNew England Journal of Medicine, 1997
- Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice.Journal of Clinical Investigation, 1997
- Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits?BMJ, 1996
- ALCOHOL, CORONARY DISEASE, AND HYPERTENSIONAnnual Review of Medicine, 1996
- Mortality associated with moderate intakes of wine, beer, or spiritsBMJ, 1995
- The effect of probucol on femoral atherosclerosis: The Probucol Quantitative Regression Swedish Trial (PQRST)The American Journal of Cardiology, 1994
- High-density lipoprotein cholesterol and alcohol consumption in US white and black adults: data from NHANES II.American Journal of Public Health, 1993
- Relation of moderate alcohol consumption and risk of systemic hypertension in womenThe American Journal of Cardiology, 1990